Environmental concerns in China leading to closure of factories that make the basic raw...
Environmental concerns in China leading to closure of factories that make the basic raw materials and key starting materials required for the API industry to be dearer?
There has been a consistent increase in KSM...
Getting the Supply Chain Right for Biologics
The relationship between pharmaceutical and biopharmaceutical companies and drug delivery system manufacturers has evolved over the past 20 years. In the past, the relationships were purely transactional, but this has changed over the last...
RABS and isolator cleanroom technology combined in V-CRT®
Significant innovation in disease treatment, including the increased focus on complex biologic therapies1, has resulted in important industry trends that have had an impact on many aspects of aseptic processing.
For example:
Pharmaceutical portfolios are...
Moving Serialization Forward: Using Automated Processes To Connect Pharmaceutical Manufacturing With The Supply Chain
While the requirements for serialization in the pharmaceutical supply chain are generally regarded as inevitable counterfeiting is simply too large of a problem to not be addressed there is some uncertainty around the specifics,particularly...
Solving the Patient Recruitment Dilemma
Patient recruitment is often cited as one of the biggest challenges faced by clinical trial professionals. Many clinical trials fail because sponsors cannot recruit sufficient patients to reach their target sample size.
In fact, only...
Rebooting the life science industry with digital technology
Digital technology has been driving change throughout the life science industry for years, however the sector is currently standing on the precipice of revolutionary development – some organizations have already taken the jump towards...
The Falsified Medicines Directive – are you ready?
The Falsified Medicines Directive 2011/62/EU, which is due for adoption in February 2019, will require pharmaceuticalcompanies to apply serialisation codes to every applicable pack (OTC and some minor exemptions).
As a consequence, artwork changes will...
Full service: The expertise and efficiency of a one – stop shop
When it comes to the manufacturing of drugs, particularly highly sensitive biologics, a high-level of expertise is required. Typically, small and medium-sized pharma and biotech companies lack the knowledge and know-how necessary to cover...
Stem Cell and Regenerative Therapies for Hearing Loss
The year 2018 marks a notable milestone in the history of stem cell and regenerative medicine. It was twenty years ago, in 1998, that James Thompson and John Gearhart published methods for the creation...
A collaborative approach to innovation in Pharma
“IGNITE is a creative environment that fosters innovative thinking and encourages new ideas and enables users to have their voice heard in overcoming challenges that are faced to find new ways to better deliver...